Improving the drug development process by reducing the impact of adverse events: The case of cataracts considered

Andrew F. Smith, Alexander Klotz, I. Michael Wormstone

Research output: Contribution to journal › Article › peer-review

3 Citations (SciVal)
17 Downloads (Pure)

Search results